Literature DB >> 24132733

Treating substance use disorders in the criminal justice system.

Steven Belenko1, Matthew Hiller, Leah Hamilton.   

Abstract

The large number of individuals with substance use disorders involved in the nation's criminal justice system (CJS) represents a unique opportunity, as well as challenges, in addressing the dual concerns of public safety and public health. Unfortunately, a low proportion of those who could benefit from treatment actually receive it while involved in the CJS. This article presents a review of recent research on the effectiveness of major substance abuse treatment interventions used at different possible linkage points during criminal justice case processing, including diversion, jail, prison, and community supervision. This is followed by a discussion of key research and practice issues, including low rates of treatment access and under-utilization of medication-assisted treatment. Concluding comments discuss principles of effective treatment for offenders and identify key gaps in research and practice that need to be addressed to improve and expand provision of effective treatment for offenders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132733      PMCID: PMC3859122          DOI: 10.1007/s11920-013-0414-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  39 in total

Review 1.  The challenges of conducting research in drug treatment court settings.

Authors:  Steven Belenko
Journal:  Subst Use Misuse       Date:  2002       Impact factor: 2.164

2.  Differential outcomes of court-supervised substance abuse treatment among California parolees and probationers.

Authors:  Elizabeth Evans; Adi Jaffe; Darren Urada; M Douglas Anglin
Journal:  Int J Offender Ther Comp Criminol       Date:  2011-04-24

3.  A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Robert P Schwartz; Kevin O'Grady
Journal:  J Offender Rehabil       Date:  2012-05-01

4.  Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.

Authors:  Andiea Harris; Daniel Selling; Charles Luther; Jason Hershberger; Joan Brittain; Samuel Dickman; Alvin Glick; Joshua D Lee
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

5.  Treating opioid use under California's Proposition 36: differential outcomes by treatment modality.

Authors:  Bradley T Conner; Ashley S Hampton; Jeremy Hunter; Darren Urada
Journal:  J Psychoactive Drugs       Date:  2011-09

6.  Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation.

Authors:  Elizabeth Evans; Douglas Longshore; Michael Prendergast; Darren Urada
Journal:  J Psychoactive Drugs       Date:  2006-11

7.  High-risk offenders participating in court-supervised substance abuse treatment: characteristics, treatment received, and factors associated with recidivism.

Authors:  Elizabeth Evans; David Huang; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

8.  Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Hannah K Knudsen; Amanda J Abraham; J Aaron Johnson; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2009-07-03

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 10.  Continuing care research: what we have learned and where we are going.

Authors:  James R McKay
Journal:  J Subst Abuse Treat       Date:  2009-03
View more
  26 in total

1.  Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia.

Authors:  Hilary L Surratt; Michele Staton; Carl G Leukefeld; Carrie B Oser; J Matthew Webster
Journal:  J Addict Dis       Date:  2018-12-21

2.  Motivational tools to improve probationer treatment outcomes.

Authors:  Faye S Taxman; Scott T Walters; Lincoln B Sloas; Jennifer Lerch; Mayra Rodriguez
Journal:  Contemp Clin Trials       Date:  2015-05-22       Impact factor: 2.226

3.  Life Stressors and Sleep Problems as Predictors of the Likelihood of Lifetime Cannabis Use among Black Adults with Criminal Justice Contact.

Authors:  Paul C Archibald; Roland J Thorpe
Journal:  Ethn Dis       Date:  2021-04-15       Impact factor: 1.847

4.  Drug Treatment Accessed through the Criminal Justice System: Participants' Perspectives and Uses.

Authors:  Alana Rosenberg; Robert Heimer; Danya E Keene; Allison K Groves; Kim M Blankenship
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

5.  Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.

Authors:  William E Soares; Donna Wilson; Michael S Gordon; Joshua D Lee; Edward V Nunes; Charles P O'Brien; Milvin Shroff; Peter D Friedmann
Journal:  Drug Alcohol Depend       Date:  2018-12-03       Impact factor: 4.492

6.  Reducing harm and promoting recovery through community-based mutual aid: Characterizing those who engage in a hybrid peer recovery community organization.

Authors:  Robert D Ashford; Austin M Brown; Georgeanne Dorney; Nancy McConnell; Justin Kunzelman; Jessica McDaniel; Brenda Curtis
Journal:  Addict Behav       Date:  2019-06-26       Impact factor: 3.913

7.  The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use among an Incarcerated Population in Kentucky, 2008-2016.

Authors:  Amanda M Bunting; Grant Victor; Erika Pike; Michele Staton
Journal:  Crim Justice Policy Rev       Date:  2019-03-31

8.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

9.  Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States.

Authors:  Phillip L Marotta; Kristi L Stringer; Amar D Mandavia; Alissa Davis; Leo Beletsky; Tim Hunt; Dawn Goddard-Eckrich; Elwin Wu; Louisa Gilbert; Nabila El-Bassel
Journal:  J Addict Dis       Date:  2019-12-10

10.  Reentry interventions that address substance use: A systematic review.

Authors:  Kelly E Moore; Robyn L Hacker; Lindsay Oberleitner; Sherry A McKee
Journal:  Psychol Serv       Date:  2018-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.